Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan

Abstract Introduction Topical prostaglandin analogs (PGAs) are used to treat glaucoma and provide significant reductions in intraocular pressure (IOP). This study evaluated the efficacy and safety of latanoprostene bunod 0.024% (LBN; Vyzulta®) in Taiwanese patients with glaucoma who were switched fr...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Chen-Jui Chiu, Ying-Ying Chen, Yi-Shan Chen
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Adis, Springer Healthcare 2026-04-01
Reeks:	Ophthalmology and Therapy
Onderwerpen:	Latanoprostene bunod (LBN) Vyzulta Glaucoma Intraocular pressure (IOP) Prostaglandin (PG)
Online toegang:	https://doi.org/10.1007/s40123-026-01367-4
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!